1. Repository of OAI
Ελληνικά   English  

Browsing by Author Fountzilas, G.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 160 to 168 of 168 < previous 
TitleAuthor(s)Issue date???itemlist.???
The Value of Ca-125 Determination in the Serum of Patients with Non-Hodgkins-Lymphomas - a Preliminary-ReportPavlidis, N. A.; Bairaktari, E.; Kalefezra, J.; Nicolaides, C.; Briassoulis, E.; Seferiadis, C.; Fountzilas, G.24-Nov-2015-
The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic studyKiriakogiani-Psaropoulou, P.; Malamou-Mitsi, V.; Martinopoulou, U.; Legaki, S.; Tamvakis, N.; Vrettou, E.; Fountzilas, G.; Skarlos, D.; Kosmidis, P.; Pavlidis, N.24-Nov-2015-
The Value of Neuroendocrine Markers in Nonsmall Cell Lung-Cancer - a Comparative Immunohistopathologic StudyKiriakogianipsaropoulou, P.; Malamoumitsi, V.; Martinopoulou, U.; Legaki, S.; Tamvakis, N.; Vrettou, E.; Fountzilas, G.; Skarlos, D.; Kosmidis, P.; Pavlidis, N.24-Nov-2015-
Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumabKoutras, A. K.; Antonacopoulou, A. G.; Eleftheraki, A. G.; Dimitrakopoulos, F. I.; Koumarianou, A.; Varthalitis, I.; Fostira, F.; Sgouros, J.; Briasoulis, E.; Bournakis, E.; Bafaloukos, D.; Bompolaki, I.; Galani, E.; Kalogeras, K. T.; Pectasides, D.; Fountzilas, G.; Kalofonos, H. P.24-Nov-2015-
Vinorelbine in combination with interleukin-2 as second-line treatment in patients with metastatic melanoma. A phase II study of the Hellenic Cooperative Oncology GroupGogas, H.; Bafaloukos, D.; Aravantinos, G.; Fountzilas, G.; Tsoutsos, D.; Panagiotou, P.; Frangia, K.; Kalofonos, H. P.; Briasoulis, E.; Castana, O.; Polyzos, A.; Pectasides, D.; Ioannovich, J.24-Nov-2015-
Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2Kosmidis, P. A.; Syrigos, K.; Kalofonos, H. P.; Dimopoulos, M. A.; Skarlos, D.; Pavlidis, N.; Boukovinas, I.; Bafaloukos, D.; Pectasides, D.; Bacoyiannis, C.; Fountzilas, G.24-Nov-2015-
Weekday on-weekend off oral capecitabine: a phase I study of a continuous schedule better simulating protracted fluoropyrimidine therapyPentheroudakis, G.; Pappas, P.; Golfinopoulos, V.; Fountzilas, G.; Nikolaidou, M.; Boumba, V. A.; Vougiouklakis, T.; Nikiforidis, L.; Tzamakou, E.; Siarabi, O.; Marselos, M.; Pavlidis, N.24-Nov-2015-
Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis: a study of the Hellenic Cooperative Oncology GroupSkarlos, D. V.; Samantas, E.; Pectasides, D.; Pavlidis, N.; Kalofonos, C.; Klouvas, G.; Panoussaki, E.; Tsiakopoulos, E.; Poulakis, N.; Fountzilas, G.24-Nov-2015-
Weekly docetaxel in minimally pretreated cancer patients: a dose-escalation study focused on feasibility and cumulative toxicity of long-term administrationBriasoulis, E.; Karavasilis, V.; Anastasopoulos, D.; Tzamakou, E.; Fountzilas, G.; Rammou, D.; Kostadima, V.; Pavlidis, N.24-Nov-2015-
Showing results 160 to 168 of 168 < previous